Comparing clinical outcomes of Schirmer's test with dry eye

Video

Jeffrey Gemi, MD, Ora Inc., speaks on the highlights from his presentation comparing Schirmer's test with other clinical outcomes in dry eye.

Jeffrey Gemi, MD, director of Special Projects, Anterior Segments, Ora Inc., speaks on the highlights from a presentation on comparing Schirmer's test with other clinical outcomes in dry eye during the virtual ARVO 2021 meeting.

See more ARVO content

Related Videos
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Dr Mary Elizabeth Hartnett speaks with David Hutton of Ophthalmology Times
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Scott D Barnes, MD, CMO of STAAR Surgical
Related Content
A nurse helps a patient who uses a walker and glasses. Image credit: ©Dorde – stock.adobe.com

Collaborative rheumatologic–ophthalmologic teams could improve management of patients with rheumatic diseases

December 7th 2023
Article

Austrian investigators recommend an interdisciplinary, rheumatologic–ophthalmologic approach to disease management

Carbomer-containing gels from Aacarb, Aacomer and Puroptics could be at risk of contamination. Images courtesy of MHRA.

MHRA issues safety recall for dry eye gel treatments

November 28th 2023
Article

The carbomer-containing eye gels carry risk of microbial contamination, the regulatory agency warned

A researcher in personal protective equipment looks at a white rabbit in a glass tank. Image credit: ©Elnur – stock.adobe.com

Novel 3D-printed device may offer a new method to test pharmaceuticals

November 28th 2023
Article

Moving toward eliminating drug and chemical safety testing in animals

A person holds a phone in their hand. Above the phone, icons such as a cross, a pill, a wheelchair and a syringe indicate they are looking at health information. Image credit: ©Monster Ztudio – stock.adobe.com

Harnessing digital media for enhanced patient engagement and outcomes

November 27th 2023
Article

Patients who received digital education demonstrated a better understanding of their disease and its management

A photo of downtown London. Image credit: ©zgphotography – stock.adobe.com

MHRA issues UK marketing approval for Biocon Biologics biosimilar aflibercept (YESAFILI®)

November 13th 2023
Article

The company received marketing authorisation approval in the EU earlier this year

AAO 2023: Advancements in dry age-related macular degeneration treatment

AAO 2023: Advancements in dry age-related macular degeneration treatment

November 6th 2023
Article

Peter K. Kaiser, MD, provides an overview of innovative therapies in development for patients with dry age-related macular degeneration.

© 2023 MJH Life Sciences

All rights reserved.